this is hero image

Welcome to Eversense 365

Congratulations on joining the Eversense family! Bookmark this page and access support material for any questions you have for setting up, troubleshooting and making the most of your new long-term CGM system.

Guided tutorial to support your first few days of using Eversense 365

Getting the most out of Eversense 365

Using Your System

CGM Data

About Your System

User Guides and Compatibility

Download PDF user guides for the Eversense 365 CGM System, Eversense Data Management System, and Eversense NOW App.

 

Get the latest device compatibility for the Eversense CGM App, Eversense 365 App, Eversense NOW App, and Eversense Data Management System.

 

this is 50 | 50 image

Still have questions?

The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.

To speak to a customer service member directly, give us a call. 1-844-736-7348 (844-SENSE4U)

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.


Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

 

 

PP-SENS-E3-GBL-0019